Skip to main content
. 2019 Jan 11;10(4):494–510. doi: 10.18632/oncotarget.26563

Figure 1. Patient cohort and gene expression data.

Figure 1

(A) Diagram describing the selection process for patients deemed failures and responders used for gene expression analysis. (B) Diagram of results from sparse Partial Least Squares-Discriminant Analysis (sPLS-DA). Red – failure cases, green – responder cases. (C) Heatmap of gene expression profiles from genes selected on the first component of the sPLS-DA model shows HNSCC treatment responders largely cluster separately from failures.